Celebrating our 10th anniversary – Unlock our special offer today

Exit Tikun, another victim of Australia’s tight regulation and low medical sales

One of the first companies involved in medical cannabis is the latest bankruptcy casualty in the volatile global cannabis market – citing slower than expected sales due to more rigorous than expected regulations.

Tikun Australia, formerly known as Medifarm, built a multi-million-dollar facility in the state of Queensland, where it was officially opened by then federal health minister Greg Hunt in August 2019. The company had planned to produce medicinal cannabis commercially in the first half of 2019, but Hunt said regulations had slowed the process.

Read full article
I'm already a subscriber
Author default picture

Lorraine Mullaney

Senior writer
Lorraine is responsible for writing news analysis and assisting with copy-editing. Lorraine is a copywriter and editor who has written and edited words for a wide range of audiences, from local community newspapers to consumer magazines and trade websites.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization